Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3

Dengue viruses (DENV) comprise a family of related positive-strand RNA viruses that infect up to 100 million people annually. Currently, there is no approved vaccine or therapy to prevent infection or diminish disease severity. Protection against DENV is associated with the development of neutralizi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Brien, James D., Austin, S. Kyle, Sukupolvi-Petty, Soila, O'Brien, Katie M., Johnson, Syd, Fremont, Daved H., Diamond, Michael S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology (ASM) 2010
Gaiak:
Vaccines and Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2950583/
https://ncbi.nlm.nih.gov/pubmed/20702644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01190-10
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak